Combipatch and Spotting - from FDA reports


Summary

Spotting is found among people who take Combipatch, especially for people who are 50-59 old , have been taking the drug for 2 - 5 years, also take medication Synthroid, and have Hot flush. This review analyzes which people have Spotting with Combipatch. It is created by eHealthMe based on reports of 1,493 people who have side effects when taking Combipatch from FDA , and is updated regularly.

What to expect?

If you take Combipatch and have Spotting, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Combipatch and have Spotting

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 22, 2017

1,493 people reported to have side effects when taking Combipatch.
Among them, 37 people (2.48%) have Spotting


Number of reports submitted per year:

Could Combipatch cause Spotting?

Time on Combipatch when people have Spotting *:

  • < 1 month: 33.33 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 66.67 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Age of people who have Spotting when taking Combipatch *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 31.58 %
  • 50-59: 42.11 %
  • 60+: 26.32 %

Top conditions involved for these people *:

  • Hot Flush (5 people, 13.51%)
  • Thyroid Diseases (3 people, 8.11%)
  • Night Sweats (3 people, 8.11%)
  • Osteoarthritis (2 people, 5.41%)
  • Sleep Disorder (1 person, 2.70%)

Top co-used drugs for these people *:

  • Synthroid (10 people, 27.03%)
  • Prilosec (7 people, 18.92%)
  • Celebrex (7 people, 18.92%)
  • Rocaltrol (6 people, 16.22%)
  • Premarin (6 people, 16.22%)

Top other side effects for these people *:

  • Chest Pain (8 people, 21.62%)
  • Weakness (7 people, 18.92%)
  • Abdominal Distension (7 people, 18.92%)
  • Neck Pain (6 people, 16.22%)
  • Narcolepsy (6 people, 16.22%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Spotting when taking Combipatch?

Expand the study to include all drugs with the same ingredients

Spotting and drugs with ingredients of estradiol; norethindrone acetate.

Expand the study to include reports from both FDA and eHealthMe

Spotting and Combipatch from FDA and eHealthMe reports

Combipatch

Combipatch has active ingredients of estradiol; norethindrone acetate. It is often used in menopause. (latest outcomes from Combipatch 1,540 users)

Spotting

Spotting (bleed during pregnancy) has been reported by people with birth control, endometriosis, heavy or prolong menstrual bleeding, depression, menstruation irregular (latest reports from 20,288 Spotting patients).

Browse all side effects of Combipatch

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Spotting

Spotting

Could your condition cause Spotting

Spotting

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Combipatch and have Spotting.

Questions to the study

More questions >

User reviews to the study

More reviews >